SVAS BIOSANA SPA (SVS.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:SVS - IT0005469264 - Common Stock
SVS.MI Key Statistics, Chart & Performance
The current stock price of SVS.MI is 7.88 EUR. In the past month the price decreased by -8.37%.
SVS.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL.PA | ESSILORLUXOTTICA | 40.35 | 128.39B | ||
| 1EL.MI | ESSILORLUXOTTICA | 38.33 | 121.95B | ||
| ESL.DE | ESSILORLUXOTTICA | 38.27 | 121.76B | ||
| GBT.PA | GUERBET | 24.3 | 187.32M | ||
| ALCJ.PA | CROSSJECT | N/A | 123.88M | ||
| AFME.PA | AFFLUENT MEDICAL SA | N/A | 74.77M | ||
| PTP.DE | PENTIXAPHARM HOLDING AG | N/A | 40.03M |
Related stock screener links
About SVS.MI
Company Profile
Svas Biosana SpA engages in distributing medical appliances. The company is headquartered in Somma Vesuviana, Napoli and currently employs 350 full-time employees. The company went IPO on 2021-12-09. The firm has two core businesses, namely industrial core and sales core. Industrial core focuses on production and marketing of medical devices, consisting of Farmex and Medical business lines. Sales core is dedicated to trading and distribution of medical devices, consisting of the SVAS and Mark Medical business lines. Farmex is focused on the production and sale of incontinence aids, traditional dressings, cotton wool and products for personal care. Medical business line focuses on production and sale of operating packs, medical devices for infusion and aspiration, linen, advanced dressings and lubricating gel for urology. SVAS is dedicated to selling specialist medical devices for medicine and surgery. Mark Medical is focused on selling medical devices. The firm operates globally.
Company Info
SVAS BIOSANA SPA
Via Trentola, 7
Somma Vesuviana NAPOLI IT
Employees: 327
Phone: 390818995411
SVAS BIOSANA SPA / SVS.MI FAQ
What does SVAS BIOSANA SPA do?
Svas Biosana SpA engages in distributing medical appliances. The company is headquartered in Somma Vesuviana, Napoli and currently employs 350 full-time employees. The company went IPO on 2021-12-09. The firm has two core businesses, namely industrial core and sales core. Industrial core focuses on production and marketing of medical devices, consisting of Farmex and Medical business lines. Sales core is dedicated to trading and distribution of medical devices, consisting of the SVAS and Mark Medical business lines. Farmex is focused on the production and sale of incontinence aids, traditional dressings, cotton wool and products for personal care. Medical business line focuses on production and sale of operating packs, medical devices for infusion and aspiration, linen, advanced dressings and lubricating gel for urology. SVAS is dedicated to selling specialist medical devices for medicine and surgery. Mark Medical is focused on selling medical devices. The firm operates globally.
Can you provide the latest stock price for SVAS BIOSANA SPA?
The current stock price of SVS.MI is 7.88 EUR. The price decreased by -5.52% in the last trading session.
Does SVAS BIOSANA SPA pay dividends?
SVAS BIOSANA SPA (SVS.MI) has a dividend yield of 3.13%. The yearly dividend amount is currently 0.3.
What is the ChartMill rating of SVAS BIOSANA SPA stock?
SVS.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the market cap for SVAS BIOSANA SPA?
SVAS BIOSANA SPA (SVS.MI) has a market capitalization of 44.13M EUR. This makes SVS.MI a Nano Cap stock.
What is the ownership structure of SVAS BIOSANA SPA (SVS.MI)?
You can find the ownership structure of SVAS BIOSANA SPA (SVS.MI) on the Ownership tab.
SVS.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to SVS.MI.
SVS.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SVS.MI. While SVS.MI is still in line with the averages on profitability rating, there are concerns on its financial health.
SVS.MI Financial Highlights
Over the last trailing twelve months SVS.MI reported a non-GAAP Earnings per Share(EPS) of 1.27. The EPS increased by 24.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.09% | ||
| ROA | 3.75% | ||
| ROE | 10.43% | ||
| Debt/Equity | 0.62 |
SVS.MI Forecast & Estimates
6 analysts have analysed SVS.MI and the average price target is 15.05 EUR. This implies a price increase of 90.93% is expected in the next year compared to the current price of 7.88.
For the next year, analysts expect an EPS growth of 33.33% and a revenue growth 19.23% for SVS.MI